Here are relevant reports on : test-automation-technology-market
-
North America Precision Farming Market by Automation & Control Systems, Cloud-based Software, System Integration & Consulting Services, Guidance Technology, Variable Rate Technology, Yield Monitoring, Variable Rate Application - Forecast to 2032
The North America precision farming market is projected to grow from USD 4.10 billion in 2025 to USD 6.46 billion by 2032, at a CAGR of 6.7% from 2025 to 2032. The Key Players include Deere & Company (US), Trimble Inc. (US), AGCO Corporation (US), Raven Industries, Inc. (US), CNH Industrial (UK), Ag Leader Technology (US), Topcon Agriculture (Japan), Climate LLC (US), Kubota Corporation (Japan), and TeeJet Technologies (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Europe Precision Farming Market by Automation & Control Systems, Cloud-based Software, System Integration & Consulting Services, Guidance Technology, Variable Rate Technology, Yield Monitoring, Variable Rate Application - Forecast to 2032
The precision farming market in Europe is projected to grow from USD 3.11 billion in 2025 to USD 6.30 billion by 2032, at a CAGR of 10.6% from 2025 to 2032. The key Players Deere & Company (US), CNH Industrial NV (UK), AGCO Corporation (US), CLAAS KGaA GmbH (Germany), Kubota Corporation (Japan), Trimble Inc. (US), Topcon Positioning Systems (Japan), Hexagon Agriculture (Sweden), Raven Industries Inc. (US), and TeeJet Technologies (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
COVID 19 Impact on IVD (In Vitro Diagnostics) Market by Technology (PCR, NGS, ELISA, Rapid Test, Hematology, Hemostasis, Clinical Chemistry, Microbiology Testing, Urinalysis), End-user and Region - Global Forecast to 2025
The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, some of the prominent players in the in-vitro diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Biomerieux (France), and QIAGEN (Germany), among others.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
Cardiovascular Ultrasound System Market by Test Type (Transesophageal, Stress, Transthoracic, Fetal), Technology (2D, 3D & 4D, Doppler Imaging), Device Display (Black & White, Color), End User (Hospitals, Home Care, Ambulatory)- Global Forecast to 2022
The global cardiovascular ultrasound system market size is projected to grow at a CAGR of 5.4%. The market is segmented on the basis of test type, technology, device display, end user, and region. Based on test type, the market is categorized into transthoracic echocardiogram, transesophageal echocardiogram, stress echocardiogram, and other echocardiograms. The other echocardiograms include fetal & intracardiac echocardiograms.
- Published: December 2016
- Price: $ 4950
- TOC Available:
-
CT/NG Testing Market by Product (Assays, Kits & Analyzers), Test Type (Laboratory, Point-of-care Testing), Technology (INAAT, PCR, Immunodiagnostics), End User (Diagnostic Labs, Hospitals & Clinics) & Region - Global Forecast to 2028
The global CT/NG testing market, valued at US$1.6 billion in 2022, stood at US$1.7 billion in 2023 and is projected to advance at a resilient CAGR of 8.6% from 2023 to 2028, culminating in a forecasted valuation of US$2.7 billion by the end of the period. Market growth is largely driven by the increasing prevalence of CT/NG infections and the growing investments and funding for R&D in CT/NG diagnosis.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Sepsis Diagnostics Market by Technology (Microbiology, PCR, Immunoassay, microfluidics, Biomarker), Product (Media, Reagent, Instrument), Method (Automated), Test (Lab, POC), Pathogen (Bacterial, Fungal), End User & Region - Global Forecast to 2029
The global sepsis Diagnostics market, valued at US$566 million in 2022, stood at US$634 million in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$890 million by the end of the period. The market growth is driven ongoing transformation of the US & European health systems towards value-based care, recent advances in biomarker-based diagnostic methods, and technological innovations in molecular diagnostics.
- Published: April 2024
- Price: $ 4950
- TOC Available:
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Blood Screening Market by Product (Reagent & Kits, Instrument, Software), Technology (NAT, (Real-Time PCR), ELISA (Chemiluminescence Immunoassay), Rapid Test, Western Blot), End User (Blood Bank, Hospital), & Region - Global Forecast to 2028
The global blood screening market, valued at US$2.3 billion in 2022, stood at US$2.4 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.4 billion by the end of the period. The need for blood is ever-increasing, forcing the number of blood donations to rise as well throughout the world. Combining this factor along with the growing infectious diseases is the major contributor for the growing blood screening market.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End User (Pharma & Biotech) & Region - Global Forecasts to 2025
The global oxidative stress assay market growth is primed to transition from USD 836 million in 2020 to USD 1,326 million by 2025, showcasing a strong CAGR of 9.7%. Growth in the oxidative stress assay market is attributed to factors such as the biopharmaceutical industry and increasing public-sector funding for academic research.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Supplement Testing Market by Test Type (Identity/Authentication, Potency, Contaminants, Microbiological, and Others), Product Tested (Ingredients and Finished Products), Technology, End-use, Service Provider, and Region – Global Forecast to 2030
The dietary supplements testing market is estimated at USD 2,400.0 million in 2025 and is projected to reach USD 3,652.2 million by 2030, at a CAGR of 8.8%. The report profiles key players such as Eurofins Scientific (Luxembourg), SGS Société Générale de Surveillance SA (Switzerland), Intertek Group plc (UK), Mérieux NutriSciences (US), UL Solutions (US), TÜV SÜD (Germany), ALS (Australia), Tentamus (Italy), Agrolab Group (Germany), FoodChain ID (US), Certified Laboratories (US), Element Materials Technology (UK), NSF (US), Vimta Labs Ltd. (India), Qalitex (US), Alkemist (US), and Anresco Laboratories (US).
- Published: August 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
